http://www.melogia.com Buy this song through iTunes and 33% of the profits will go to the American Lung Association. Visit: https://itunes.apple.com/us/artist/sarantos/id784136489?ign-mpt=uo%3D4
2nd Soft Rock Music Video Released By Emerging Artist Sarantos -
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. While several leading cancer centers have only begun introducing immunotherapy, Issels has been a leader in Integrative Immunotherapy for decades.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7224051-issels-integrative-immunotherapy-lung-cancer-advanced-treatment
Click: http://www.melogia.com New Folk Indie Top 40 song "What If I Never See You Again" by Sarantos.
Questions that will run through one's mind as they deal with the death of a parent are too numerous to list. Sarantos knows this firsthand since his father passed away after a long, hard fought battle with lung cancer. Sarantos captures the essence of this frustration and exasperation one sleepless night and this folk song was born. The song, melody, rhythm and length fit the mood and feel of this tortured night.
33% of any music-related sales profits from this song are going straight to The National Center For Fathering.
Additional Links:
https://www.facebook.com/Sarantosmelogia
http://www.twitter.com/sarantosmelogia
http://www.youtube.com/user/SarantosMelogia
http://bit.ly/SarantosAppleStore
Inchirieri Auto pe termen lung in Bucuresti - servicii de leasing operational in Romania
Promotor Rent a Car este o companie autohtona care ofera servicii de inchirieri auto si leasing operational in Bucuresti dar si in principalele orase din Romania: Arad, Bacau, Brasov, Cluj, Constanta, Iasi, Timisoara, Suceava, Otopeni. Sibiu, Targu Mures.
Inchirierea pe temen lung - leasing operational este alegerea perfecta pentru companiile mici si mijlocii.
Promotor Rent a Car ofera servicii de inchiriere auto pe termen lung in Bucuresti si in toate orasele din Romania, oferind autoturisme noi, mentenanta gratuita si garantie financiara 0.
Oferim o gama variata de masini de inchiriat noi, inchirieri auto ieftine cu toate taxele incluse: Tva, Asigurare Rca si Casco, Taxa de drum (Rovinieta) si Km nelimitati. Rezervati o masina de la Promotor Rent a Car si veti putea sa o anulati oricand fara nicio taxa. Preturile pentru masinile inchiriate in Bucuresti au toate taxele incluse si nu au alte taxe ascunse.
Promotor Rent a Car Bucuresti ofera garantia unei calatorii placute in cele mai bune conditii de inchiriere. Constant oferim reduceri substantiale de pret in Bucuresti atat pentru membrii nostri cat si pentru clentii noi. Mai multe detalii puteti gasi pe site-ul: https://www.inchirieri-masini-bucuresti.ro
Verifica acum oferta de pret pentru masinile de inchiriat pe termen lung din Bucuresti si rezerva o masina fara nicio obligatie. Suntem aici pentru clientii nostri si ne dam silinta sa oferim conditii flexibile de inchiriere.
Promotor Rent a Car iti poate oferi servicii de inchirieri auto pe termen lung, pentru atata timp cat ai nevoie.
Pentru mai multe detalii va rugam sa vizitati site-ul https://www.auto-rent.ro/ro/inchirieri-auto-termen-lung.html si https://www.promotor-rentacar.ro/inchirieri-auto/bucuresti.html sau ne puteti suna la 0734 403 403
Today, the American Lung Association's LUNG FORCE initiative is joining forces with Academy Award®-nominated actress, Laura Dern, country music star Kellie Pickler, and Emmy- and Golden Globe-winning actress, Valerie Harper, during National Women’s Lung Health Week (May 10th -16th) to share their voices in an effort to defeat lung cancer in women.
Every eight minutes, a woman in the United States dies of lung cancer. It is the #1 cancer killer of women, killing almost twice as many women as any other cancer. Yet, awareness is extremely low. Only 1 percent of women cite lung cancer as a women’s cancer that is top-of-mind for them, according to the American Lung Association's Women's Lung Health Barometer. Now in its second year, LUNG FORCE, in partnership with national presenting sponsor, CVS Health, is empowering women and men everywhere to share their voices and make lung cancer a public health priority.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7521751-ala-lung-force-cancer-women/
With the onset of winter season in the country, breathing problems and respiratory diseases will also be on the rise. To ensure that patients with respiratory problems breathe with ease, a comprehensive patient Mobile App named “My Breathefree” has been launched as a virtual caregiver by ‘Breathefree’, a public service initiative by Cipla. This app is specifically designed for Indian conditions and is available on Google play store and iOS platform for all patients, caregivers and doctors.
One of the major chronic respiratory problems in the country is asthma and “My Breathefree” app will be a great help towards better asthma management and control. Asthma causes limitations in daily activities, loss of school and work days, lung function impairment, reduced quality of life and an adverse socioeconomic burden. However, if monitored and treated properly, asthmatics can control their disease and lead an absolutely normal and healthy life.
To view the multimedia release go to:
http://www.multivu.com/players/English/7562351-lung-care-asthma-mobile-app/
CVS Health, the nation’s largest pharmacy innovation company, today launched an in-store fundraising campaign at CVS Pharmacy locations nationwide to benefit the American Lung Association’s LUNG FORCE initiative which aims to make lung cancer, the leading cancer killer of women in the United States, a public health priority.
Now through June 11, customers can donate $1, $3 or more at the register at 7,900 CVS Pharmacy locations and online at www.cvs.com/lung (all proceeds will support the initiative). CVS Health is the national presenting sponsor of LUNG FORCE, which is focused on raising awareness about lung cancer in women, and increasing research funding to save lives.
To view the multimedia release go to:
http://www.multivu.com/players/English/7817251-cvs-health-lung-force-fundraiser/
The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its “From Hope to Cures” campaign, highlighting the stories of rare blood and lung cancer survivors.
The newest video in the collection features Matt, who was diagnosed nearly seven years ago with advanced non-small cell lung cancer. When he was diagnosed, he was given a slim chance of living up to five years. However, today Matt continues to lead an active life due to recent advancements in targeted gene therapies and innovations in cancer medicines.
The latest print and digital ads feature Jamie, a vibrant woman diagnosed 15 years ago with chronic myelogenous leukemia (CML). Watching her son grow up was a primary focus for her, and she’s been able to continue to do that and so much more. Thanks to advancements in CML treatments, today she maintains her sense of humor and imparts an infectious joy on those who meet her.
Earlier this year, the first collection of digital and print ads was released featuring Rhys, a five-year-old living with type 1 diabetes and celiac disease. Unveiled alongside the advertising was a video, titled “We’re Fighting Back,” which features both Rhys and Jamie, as well as Jen, a researcher who wakes up every day working to find new treatments and cures for patients.
To view the multimedia release go to:
http://www.multivu.com/players/English/7738431-phrma-from-hope-to-cures/
To kick off Lung Cancer Awareness Month this November, the American Lung Association’s LUNG FORCE initiative, nationally presented by CVS Health, today announced its partnership with Grammy Award-winning singer Patti LaBelle to further educate the public about lung cancer, the leading cancer killer of women in the United States.
Personally affected by lung cancer, LaBelle hopes that lending her powerful voice to the cause will encourage all women to learn how they can make a difference in the fight to defeat lung cancer, which claims the life of one woman every eight minutes in the United States. Raising awareness is critical as only 1 percent of American women even have lung cancer on their health radar.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7664651-lung-force-patti-labelle-educate-public/
Madison Taliaferro spent weeks in the hospital in 2012. After a decade of suffering from cystic fibrosis, she underwent a double lung transplant. She powered through the difficult surgery and the recovery that followed –long days of physical therapy and rehabilitation. Her parents were there. Her best friend visited from Kansas. Grandparents rotated shifts so she was never alone. But one request still lingered.
“I just wanted to see my dogs,” she remembers.
Having suffered from the effects of chronic illness for the decade prior, Madison was no stranger to long days at home, isolated from the school germs that could turn her illness into a critical condition with a single sneeze. When her friends couldn’t visit, her dogs were there. But at the hospital, they weren’t.
To view the multimedia release go to:
http://www.multivu.com/players/English/7835951-purina-family-pet-center-st-louis-childrens/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
